Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure.

Authors

• Karen E Joynt
• Wendy A Gattis
• Vic Hasselblad
• Sergey Y Fuzaylov
• Victor L Serebruany
• Paul A Gurbel
• Laura H Gaulden
• G Michael Felker
• David J Whellan
• Christopher M O'Connor

Publication/Presentation Date

3-15-2004

Abstract

C-reactive protein (CRP) levels were measured in a cohort of 96 outpatients with heart failure. Baseline angiotensin-converting enzyme inhibitor plus beta-blocker use were associated with lower levels of CRP; no relation was found between CRP levels and aspirin or statin use.

Volume

93

Issue

6

First Page

783

Last Page

785

ISSN

0002-9149

Published In/Presented At

Joynt, K. E., Gattis, W. A., Hasselblad, V., Fuzaylov, S. Y., Serebruany, V. L., Gurbel, P. A., Gaulden, L. H., Felker, G. M., Whellan, D. J., & O'Connor, C. M. (2004). Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure. The American journal of cardiology, 93(6), 783–785. https://doi.org/10.1016/j.amjcard.2003.12.010

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

15019895

Department(s)

Administration and Leadership

Document Type

Article